1-6 of 6
Philip R. Greipp, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Sumit Madan, M.D., Angela Dispenzieri, M.D., Martha Q. Lacy, MD, Francis Buadi, M.D., Suzanne R. Hayman, MD, Kristin Detweiler, R.N., C.N.P, Steven R. Zeldenrust, M.D., Ph.D., David Dingli, M.D., PhD., Philip R Greipp, M.D., Stephen J. Russell, MD, PhD, John A. Lust, MD, PhD, Robert A Kyle, MD, S. Vincent Rajkumar, M.D., Morie A Gertz, M.D., Shaji K Kumar, MD
Journal: Blood
Blood (2009) 114 (22): 4867.
https://doi.org/10.1182/blood.V114.22.4867.4867
Published: 2009
Journal Articles

Cardiac Biomarkers Predict for Ability To Tolerate and Complete Therapy with Lenalidomide ± Dexamathosone in AL Amyloidosis.

Angela Dispenzieri, MD, Martha Lacy, M.D., Steven Zeldenrust, M.D., Ph.D., Suzanne R. Hayman, M.D., Shaji Kumar, M.D., Susan M. Geyer, Ph.D., John A. Lust, M.D., Ph.D., Jacob B. Allred, M.S., Thomas E. Witzig, M.D, S. Vincent Rajkumar, M.D., Philip R. Greipp, M.D., Stephen J. Russell, M.D., Ph.D., Brian Kabat, Morie Abraham Gertz, M.D.
Journal: Blood
Blood (2006) 108 (11): 130.
https://doi.org/10.1182/blood.V108.11.130.130
Published: 2006
Journal Articles

Single Agent Bortezomib Is Associated with a High Response Rate in Patients with High Risk Myeloma. A Phase II Study from the Eastern Cooperative Oncology Group (E2A02).

Angela Dispenzieri, MD, Lijung Zhang, M.S., Rafael Fonseca, M.D., David H. Vesole, M.D., Ph.D., Philip R. Greipp, M.D.
Journal: Blood
Blood (2006) 108 (11): 3527.
https://doi.org/10.1182/blood.V108.11.3527.3527
Published: 2006
Journal Articles

Deletion 13 by FISH Provides Prognostic Information on Overall Survival and Time to Progression Independent of Serum Beta 2 Microglobulin and Bone Marrow Plasma Cell Labeling Index in Myeloma Patients Undergoing Stem Cell Transplantation.

Morie Abraham Gertz, M.D., Martha Q. Lacy, M.D., Angela Dispenzieri, M.D., Philip R. Greipp, M.D., Mark R. Litzow, M.D., Kim J. Henderson, BA, Scott VanWier, BA, Greg Ahmann, BA, Rafael Fonseca, M.D.
Journal: Blood
Blood (2004) 104 (11): 4852.
https://doi.org/10.1182/blood.V104.11.4852.4852
Published: 2004
Journal Articles

PS-341 Induces Selective Radiosensitization of Multiple Myeloma Cells.

Apollina Goel, Ph.D., Angela Dispenzieri, M.D., Philip R. Greipp, M.D., Thomas E. Witzig, M.D., Ruben A. Mesa, M.D., Stephen J. Russell, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2478.
https://doi.org/10.1182/blood.V104.11.2478.2478
Published: 2004
Journal Articles

Plasma Cell Folate Receptor Overexpression Differentiates Multiple Myeloma from Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma.

Patricia Greipp, D.O., Greg Cascino, Teresa Kimlinger, Vincent Rajkumar, M.D., Franklyn G. Prendergast, Ph.D., M.D., Rafael Fonseca, M.D., P. Leif Bergsagel, M.D., Philip S. Low, Ph.D., Philip R. Greipp, M.D.
Journal: Blood
Blood (2004) 104 (11): 3649.
https://doi.org/10.1182/blood.V104.11.3649.3649
Published: 2004